V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007210 | 310004363 | 1.6 | 54.5 | Palliative (P) | 2017-03-01 | 2017-03-08 | PEMBROLIZUMAB | N | N | 310016804 | PEMBROLIZUMAB |
| 310007211 | 310004364 | null | 94.8 | Curative (C) | 2015-08-06 | 2015-08-14 | BEAM | 2 | N | 310016833 | BEAM |
| 310007212 | 310004368 | 1.63 | 71.1 | Palliative (P) | null | 2018-05-02 | GEM-P | N | N | 310016833 | GEMCITABINE + PACLITAXEL |
| 310007213 | 310007828 | 1.7 | 50.6 | Palliative (P) | 2016-02-22 | 2016-03-04 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310016840 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007214 | 310004371 | null | 70.6 | null | null | 2013-07-01 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016854 | CISPLATIN + GEMCITABINE |
| 310007215 | 310004372 | 1.9 | 87.6 | Disease modification (D) | 2015-12-14 | 2016-01-19 | GEM-P | N | N | 310016856 | GEMCITABINE + PACLITAXEL |
| 310007216 | 310004373 | 1.19 | null | Disease modification (D) | 2013-02-28 | 2013-03-01 | Trial Unspecified + MEDI4736 | N | null | 310016872 | NOT MATCHED |
| 310007217 | 310004374 | 1.59 | null | Palliative (P) | null | 2013-08-28 | BEAM | 01 | N | 310016876 | BEAM |
| 310007218 | 310004375 | 1.57 | 62 | Palliative (P) | 2015-01-28 | 2015-01-28 | BEAM | 02 | N | 310016882 | BEAM |
| 310007219 | 310004376 | 1.7 | 70.4 | Curative (C) | 2017-11-03 | 2017-11-05 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310016885 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007220 | 310007832 | null | null | Palliative (P) | 2018-06-08 | 2018-11-24 | Brentuximab | N | N | 310016898 | BRENTUXIMAB |
| 310007221 | 310004379 | 1.79 | null | Curative (C) | 2016-05-15 | 2016-05-16 | IVE | N | N | 310016909 | IVE |
| 310007222 | 310007833 | 1.77 | 53.3 | Palliative (P) | 2013-03-27 | 2014-04-26 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310016909 | CISPLATIN + GEMCITABINE |
| 310007223 | 310004381 | 1.8 | null | Curative (C) | 2016-06-08 | 2016-06-14 | ALEMTUZUMAB + CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | N | N | 310016929 | NOT MATCHED |
| 310007224 | 310004381 | 0 | 76.6 | Palliative (P) | 2014-12-28 | 2015-01-21 | ALL UKALL2011 Maintenance C4 | N | null | 310016929 | NOT MATCHED |
| 310007225 | 310004384 | null | 120 | Curative (C) | 2013-10-10 | 2013-10-11 | IVE | N | N | 310016946 | IVE |
| 310007226 | 310004385 | 0 | 62.4 | Curative (C) | 2017-01-09 | 2017-04-14 | LEAM | N | N | 310016946 | LEAM |
| 310007227 | 310004385 | 1.18 | 54.1 | Curative (C) | 2016-06-22 | 2016-07-13 | null | N | N | 310016946 | NOT MATCHED |
| 310007228 | 310004385 | 1.78 | 66.8 | Palliative (P) | 2017-03-20 | 2017-03-24 | Gemcitabine + Paclitaxel | N | null | 310016946 | GEMCITABINE + PACLITAXEL |
| 310007229 | 310004385 | 1.5 | null | null | 2015-05-26 | 2015-10-08 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310016946 | GEMCITABINE |
| 310007233 | 310007840 | 1.87 | 54.9 | Curative (C) | 2017-10-19 | 2017-11-10 | Brentuximab | 02 | N | 310017062 | BRENTUXIMAB |
| 310007234 | 310007840 | 1.8 | 102.6 | Palliative (P) | null | 2016-08-21 | GEM-P | N | N | 310017062 | GEMCITABINE + PACLITAXEL |
| 310007235 | 310004392 | 1.62 | 60.2 | Palliative (P) | null | 2015-02-19 | GEM-P | 02 | null | 310017080 | GEMCITABINE + PACLITAXEL |
| 310007236 | 310004394 | 1.69 | 58.3 | Palliative (P) | null | 2018-03-16 | Gemcitabine weekly | N | N | 310017080 | GEMCITABINE |
| 310007237 | 310004395 | null | 72 | Palliative (P) | null | 2013-12-30 | Bortezomib + Prednisolone + CYCLOPHOSPHAMIDE + Prednisolone + DOXORUBICIN + Prednisolone + Prednisolone + RITUXIMAB + Prednisolone + VINCRISTINE | N | N | 310017082 | NOT MATCHED |
| 310007238 | 310004396 | 1.7 | 111.3 | Disease modification (D) | 2016-06-30 | 2016-07-01 | Brentuximab | Y | N | 310017149 | BRENTUXIMAB |
| 310007239 | 310004396 | null | 63 | Palliative (P) | 2014-10-07 | 2014-10-10 | null | N | N | 310017149 | NOT MATCHED |
| 310007240 | 310004397 | 1.79 | null | Palliative (P) | 2015-12-25 | 2016-05-06 | PEMBROLIZUMAB | N | N | 310017154 | PEMBROLIZUMAB |
| 310007241 | 310007845 | 1.78 | null | Disease modification (D) | 2016-02-04 | 2016-02-05 | Gemcitabine weekly | N | N | 310017154 | GEMCITABINE |
| 310007242 | 310007846 | 1.5 | 71 | Curative (C) | 2015-05-28 | 2015-06-02 | IVE | N | N | 310017180 | IVE |
| 310007243 | 310004401 | 1.69 | 73.85 | Curative (C) | 2017-07-11 | 2017-07-14 | LEAM | N | N | 310017185 | LEAM |
| 310007244 | 310007847 | 1.81 | 84.1 | Palliative (P) | null | 2016-10-31 | Gemcitabine + Methylprednisolone | N | N | 310017192 | GEMCITABINE |
| 310007245 | 310004402 | 0 | null | Disease modification (D) | 2015-03-07 | 2015-03-26 | null | N | N | 310017198 | NOT MATCHED |
| 310007246 | 310004403 | 1.65 | 61.4 | Curative (C) | 2017-03-25 | 2017-04-11 | IVE | N | N | 310017198 | IVE |
| 310007247 | 310010670 | null | 83 | Palliative (P) | 2017-05-19 | 2017-05-24 | Brentuximab | 2 | N | 310017220 | BRENTUXIMAB |
| 310007248 | 310004404 | 1.6 | 63 | null | 2017-05-05 | 2017-05-22 | IVE | N | N | 310017224 | IVE |
| 310007249 | 310004404 | null | 70.4 | Palliative (P) | 2014-04-05 | 2014-04-12 | Brentuximab | N | N | 310017224 | BRENTUXIMAB |
| 310007250 | 310004405 | null | null | Curative (C) | 2016-01-14 | 2017-02-12 | IVE | 2 | N | 310017235 | IVE |
| 310007251 | 310004408 | 1.62 | 79 | Curative (C) | 2015-01-12 | 2015-01-29 | CYTARABINE + ETOPOSIDE + MELPHALAN EAM (no cytarabine) autologous translant | N | N | 310017246 | NOT MATCHED |
| 310007252 | 310004408 | 1.69 | 54.3 | Curative (C) | 2016-08-08 | 2016-08-13 | IVE | N | N | 310017246 | IVE |
| 310007253 | 310007851 | 1.69 | 69 | Adjuvant (A) | 2015-02-19 | 2015-02-19 | BEAM | N | Y | 310017252 | BEAM |
| 310007254 | 310004412 | 1.8 | 82 | Palliative (P) | 2014-07-29 | 2014-08-27 | Carboplatin + Liposomal Doxorubicin | N | N | 310017269 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007255 | 310004412 | 149 | 77 | Palliative (P) | 2017-04-20 | 2017-04-27 | PEMBROLIZUMAB | N | N | 310017269 | PEMBROLIZUMAB |
| 310007256 | 310004413 | 1.62 | 71.9 | Palliative (P) | 2014-05-28 | 2014-05-28 | PEMBROLIZUMAB | 02 | N | 310017276 | PEMBROLIZUMAB |
| 310007257 | 310004417 | null | 23.05 | null | 2016-02-02 | 2016-02-02 | Brentuximab | 02 | N | 310017279 | BRENTUXIMAB |
| 310007258 | 310004417 | null | 14.4 | Palliative (P) | 2016-05-22 | 2016-06-03 | GEM-P | N | N | 310017279 | GEMCITABINE + PACLITAXEL |
| 310007259 | 310004419 | 1.65 | 54.3 | Curative (C) | 2018-09-29 | 2018-10-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017284 | CISPLATIN + GEMCITABINE |
| 310007260 | 310004421 | 1.61 | 61.2 | Palliative (P) | 2017-12-26 | 2018-01-08 | GEM-P | N | N | 310017289 | GEMCITABINE + PACLITAXEL |
| 310007261 | 310004422 | 1.79 | null | Not known (9) | 2018-05-15 | 2018-08-02 | LEAM | 2 | N | 310017292 | LEAM |
| 310007262 | 310007858 | 1.58 | null | Palliative (P) | 2014-07-18 | 2014-07-27 | Carboplatin + Liposomal Doxorubicin | N | N | 310017300 | CARBOPLATIN + LIPOSOMAL DOX |